1 |
Yoshida K, Takahashi JC, Takenobu Y, et al. Strokes associated with pregnancy and puerperium: A nationwide study by the Japan stroke society [J]. Stroke, 2017, 48(2): 276-282.
|
2 |
Bushnell C, Mccullough L. Stroke prevention in women: synopsis of the 2014 American Heart Association/American Stroke Association guideline [J]. Ann Intern Med, 2014, 160(12): 853-857.
URL
|
3 |
Liang CC, Chang SD, Lai SL, et al. Stroke complicating pregnancy and the puerperium [J]. Eur J Neurol, 2006, 13(11): 1256-1260.
|
4 |
Bushnell C, McCullough LD, Awad IA, et al. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association [J]. Stroke, 2014, 45(5): 1545-1588.
|
5 |
Cerneca F, Ricci G, Simeone R, et al. Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis [J]. Eur J Obstet Gynecol Reprod Biol, 1997, 73(1): 31-36.
|
6 |
AmaraI LM, Cunningham MW, Cornelius DC, et a1. Preeclampsia:long—term consequences for vascular health [J]. Vasc Health Risk Manag, 2015, 11(6): 403-415.
|
7 |
McDermott M, Miller EC, Rundek T, et al. Preeclampsia: Association with posterior reversible encephalopathy syndrome and stroke [J]. Stroke, 2018, 49(3): 524-530.
|
8 |
Sanders BD, Davis MG, Holley SL, et al. Pregnancy-associated stroke [J]. J Midwifery Womens Health, 2018, 63(1): 23-32.
|
9 |
Zambrano MD, Miller EC. Maternal Stroke: An Update [J]. Curr Atheroscler Rep, 2019, 21(9): 33.
|
10 |
Lin SY, Hu CJ, Lin HC. Increased risk of stroke in patients who undergo cesarean delivery: a nationwide population-based study [J]. Am J Obstet Gynecol, 2008, 198(4): 391-397.
|
11 |
Miller EC, Yaghi S, Boehme AK, et al. Mechanisms and outcomes of stroke during pregnancy and the postpartum period: a cross-sectional study [J]. Neurol Clin Pract, 2016, 6(1): 29-39.
|
12 |
Kupferminc MJ, Yair D, Bornstein NM, et al. Transient focal neurological deficits during pregnancy in carriers of inherited thrombophilia [J]. Stroke, 2000, 31(4): 892-895.
|
13 |
James AH, Bushnell CD, Jamison MG, et al. Incidence and risk factors for stroke in pregnancy and the puerperium [J]. Obstet Gynecol, 2005, 106(3): 509-516.
|
14 |
Ogilvy CS, Stieg PE, Awad I, et al. AHA Scientific Statement: recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association [J]. Stroke, 2001, 32(6): 1458-1471.
|
15 |
Bateman BT, Schumacher HC, Bushnell CD, et al. Intracerebral hemorrhage in pregnancy. Frequency, risk factors, and outcome [J]. Neurology, 2006, 67(3): 424-429.
|
16 |
Grear KE, Bushnell CD. Stroke and pregnancy: clinical presentation, evaluation, treatment and epidemiology [J]. Clin Obstet Gynecol, 2013, 56(2): 350-359.
URL
|
17 |
Jeng JS, Tang SC, Yip PK. Incidence and etiologies of stroke during pregnancy and puerperium as evidenced in Taiwanese women [J]. Cerebrovasc Dis, 2004, 18(4): 290-295.
|
18 |
Skidmore FM, Williams LS, Fradkin KD, et al. Presentation, etiology, and outcome of stroke in pregnancy and puerperium [J]. J Stroke Cerebrovasc Dis, 2001, 10(1): 1-10.
|
19 |
Alsheikh-Ali AA, Thaler DE, Kent DM. Patent foramen ovale in cryptogenic stroke: incidental or pathogenic [J]. Stroke, 2009, 40(7): 2349-2355.
|
20 |
Beroyz G, Casale R, Farreiros A, et al. CLASP-A randomized trial of low-dose aspirin for the prevention and treatment of preeclampsia among 9364 pregnant-women [J]. Lancet, 1994, 343(8898): 619-629.
|
21 |
Demaerschalk BM, Kleindorfer DO, Adeoye OM, et al. Scientific rationale rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: A statement for healthcare professionals from the american heart association/ american stroke association [J]. Stroke, 2016, 47(2): 581-641.
|
22 |
Leffert LR, Clancy CR, Bateman BT, et al. Treatment patterns and short-term outcomes in ischemic stroke in pregnancy or postpartum period [J]. Am J Obstet Gynecol, 2016, 214(6): 721-723.
|
23 |
Kular S, Ram R, Balian V, et al. Mechanical thrombectomy for acute stroke in pregnancy [J]. Neuroradiol J, 2020, 33(2): 134-139.
|
24 |
Ladhani NNN, Swartz RH, Foley N, et al. Canadian Stroke Best Practice Consensus Statement: Acute Stroke Management during pregnancy [J]. Int J Stroke, 2018, 13(7): 743-758.
|
25 |
Bousser MG, Crassard I. Cerebral venous thrombosis, pregnancy and oral contraceptives [J]. Thromb Res, 2012, 130(Suppl 1): S19-S22.
URL
|
26 |
Saposnik G, Barinagarrementeria F, Brown R, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association [J]. Stroke, 2011, 42(4):1158-1192.
URL
|
27 |
Liang ZW, Gao WL, Feng LM. Clinical characteristics and prognosis of cerebral venous thrombosis in Chinese women during pregnancy and puerperium [J]. Sci Rep, 2017, 7(6): 43866.
|
28 |
Ferro JM, Aguiar de Sousa D. Cerebral Venous Thrombosis: an Update [J]. Curr Neurol Neurosci Rep, 2019, 19(10): 74.
|
29 |
Coutinho JM, Ferro JM, Canhão P, et al. Cerebral venous and sinus thrombosis in women [J]. Stroke, 2009, 40(7): 2356-2361.
|
30 |
Del Zotto E, Giossi A, Volonghi I, et al. Ischemic stroke during pregnancy and puerperium [J]. Stroke Res Treat, 2011, 2011(1): 606780.
|
31 |
Aguiar de Sousa D, Canhão P, Crassard I, et al. Safety of pregnancy after cerebral venous thrombosis results of the ISCVT (International Study on Cerebral Vein and Dural Sinus Thrombosis)-2 PREGNANCY study [J]. Stroke, 2017, 48(11): 3130-313.
|
32 |
Sousa DAD, Canhao P, Ferro JM, et al. Safety of pregnancy after cerebral venous thrombosis--A systematic review [J]. Stroke, 2017, 47(3): 713-718.
|
33 |
Rottenstreich A, Gershgoren H, Spectre G, et al. Factors associated with pregnancy outcomes in women with a history of cerebral sinus venous thrombosis [J]. J Thromb Thrombolysis, 2019. Online ahead of print.
|
34 |
Sharshar T, Lamy C, Mas JL. Stroke in pregnancy study group. Incidence and causes of stroke associated with pregnancy and puerperium: a study in public hospitals of Ile de France [J]. Stroke, 1995, 26(6): 930-936.
|
35 |
Kittner SJ, Stern BJ, Feeser BR, et al. Pregnancy and the risk of stroke [J]. N Engl J Med, 1996, 335(7): 768-774.
|
36 |
Ascanio LC, Maragkos GA, Young BC, et al. Spontaneous Intracranial Hemorrhage in Pregnancy: A Systematic Review of the Literature [J]. Neurocrit Care, 2019, 30(1): 5-15.
|
37 |
Lumbers ER, Stevens AD. Changes in fetal renal function in response to infusions of a hyperosmotic solution of mannitol to the ewe [J]. J Physiol, 1983, 343(10): 439-446.
|
38 |
Burgess AM, Vere DW. Teratogenic effects of some calcium channel blocking agents in Xenopus embryos [J]. Pharmacol Toxicol, 1989, 64(1): 78-82.
|
39 |
Euser AG, Cipolla MJ. Magnesium sulfate for the treatment of eclampsia: a brief review [J]. Stroke, 2009, 40(4): 1169-1175.
|
40 |
Dias MS, Sekhar LN. Intracranial hemorrhage from aneurysms and Arteriovenous malformations during pregnancy and the puerperium [J]. Neurosurgery, 1990, 27(6): 855-865.
|
41 |
Trivedi RA, Kirkoatriek PJ. Arteriovenous malformations of the cerebral circulation that rupttmre in pregnancy [J]. J Obstet Gynaecol, 2003, 23(5): 484-489.
|
42 |
Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome [J]. N Engl J Med, 1996, 334(8): 494-500.
|
43 |
Postma IR, Slager S, Kremer HP, et al. Long-term consequences of the posterior reversible encephalopathy syndrome in eclampsia and preeclampsia: a review of the obstetric and nonobstetric literature [J]. Obstet Gynecol Surv, 2014, 69(5): 287-300.
URL
|
44 |
Uwatoko T, Toyoda K, Hirai Y, et al. Reversible posterior leukoencephalopathy syndrome in a postpartum woman without eclampsia [J]. Intern Med, 2003, 42(11): 1139-1143.
|
45 |
Davie CA, Brim P. Stoke and pregnancy [J]. J Neurol Neurosurg Psychiatry, 2008, 79(3):240-5.
|
46 |
Roth C, Ferbert A. Posterior reversible encephalopathy syndrome: is there a difference between pregnant and non-pregnant patients? [J]. Eur Neurol, 2009, 62(3): 142-148.
|
47 |
Wolff V, Ducros A. Reversible cerebral vasoconstriction syndrome without typical thunderclap headache [J]. Headache, 2016, 56(4): 674-687.
|
48 |
Ducros A. Reversible cerebral vasoconstriction syndrome [J]. Lancet Neurol, 2012, 11(10): 906-917.
URL
|
49 |
Tanaka K, Matsushima M, Matsuzawa Y, et al. Antepartum reversible cerebral vasoconstriction syndrome with pre-eclampsia and reversible posterior leukoencephalopathy [J]. J Obstet Gynaecol Res, 2015, 41(11): 1843-1847.
|
50 |
Mijalski C, Dakay K, Miller-Patterson C, et al. Magnesium for treatment of reversible cerebral vasoconstriction syndrome: case series [J]. Neurohospitalist, 2016, 6(3): 111-113.
|